Published in Acta Pharmacol Sin on December 16, 2013
Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77
The immune system in atherosclerosis. Nat Immunol (2011) 6.51
Inflammation and atherosclerosis. Annu Rev Pathol (2006) 4.47
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A (2004) 3.85
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation (2004) 3.51
CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest (2008) 3.29
Cardiovascular biology of the incretin system. Endocr Rev (2012) 2.42
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes (2010) 2.34
Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest (2008) 2.16
Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci U S A (2004) 1.89
A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood (2005) 1.81
Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun (2006) 1.74
Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol (2012) 1.59
Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation (2002) 1.56
A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation (2012) 1.39
Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol Biol (2012) 1.38
Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. Trans Am Clin Climatol Assoc (2010) 1.27
Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies. J Am Soc Hypertens (2009) 1.21
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia (2011) 1.19
Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res (2004) 1.17
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep (2012) 1.16
Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages. Int Immunopharmacol (2008) 1.10
Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis (2005) 1.08
Sequential morphologic studies of regression of advanced atherosclerosis. Arch Pathol Lab Med (1981) 1.06
Studies of regression of advanced atherosclerosis in experimental animals and man. Ann N Y Acad Sci (1976) 1.04
Macrophage migration inhibitory factor: controller of systemic inflammation. Crit Care (2006) 1.04
The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost (2013) 1.03
The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis (2005) 1.00
Matrix matters. Circulation (2000) 0.98
Mannose receptor regulation of macrophage cell migration. J Leukoc Biol (2007) 0.96
Chemical biology for understanding matrix metalloproteinase function. Chembiochem (2012) 0.92
Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7 macrophages. J Cell Biochem (2011) 0.87
Statins and foam cell formation: impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors. Biochim Biophys Acta (2007) 0.84
Targeted deletion of the inhibitory NF-kappaB p50 subunit in bone marrow-derived cells improves collateral growth after arterial occlusion. Cardiovasc Res (2010) 0.81
Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial. Trials (2011) 0.80
The role of HDL and its modulators in the development of diabetes. Curr Opin Lipidol (2012) 0.79
Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. Am J Cardiol (2004) 0.78
Increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in human atherosclerosis. Pathol Res Pract (2010) 0.78